MAXCYTE INC's ticker is and the CUSIP is 57777K106. A total of 108 filers reported holding MAXCYTE INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $136,082 | -29.5% | 43,616 | +3.7% | 0.00% | 0.0% |
| Q2 2023 | $193,078 | -8.3% | 42,065 | -1.1% | 0.00% | 0.0% |
| Q1 2023 | $210,543 | -6.3% | 42,534 | +3.3% | 0.00% | -50.0% |
| Q4 2022 | $224,717 | -16.5% | 41,157 | -0.4% | 0.00% | 0.0% |
| Q3 2022 | $269,000 | +39.4% | 41,308 | +1.4% | 0.00% | +100.0% |
| Q2 2022 | $193,000 | -44.4% | 40,725 | -17.9% | 0.00% | -50.0% |
| Q1 2022 | $347,000 | -33.3% | 49,612 | -2.7% | 0.00% | -33.3% |
| Q4 2021 | $520,000 | +395.2% | 50,999 | +494.7% | 0.00% | +200.0% |
| Q3 2021 | $105,000 | – | 8,576 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 3,225,000 | $17,608,500 | 11.83% |
| Vitruvian Partners LLP | 5,043,356 | $27,536,724 | 5.80% |
| NORTH RUN CAPITAL, LP | 451,960 | $2,467,702 | 5.67% |
| Casdin Capital, LLC | 9,505,000 | $51,897,300 | 4.02% |
| RIVER GLOBAL INVESTORS LLP | 1,648,238 | $8,749 | 1.88% |
| Pier Capital, LLC | 1,074,164 | $5,864,935 | 0.96% |
| Montanaro Asset Management Ltd | 929,000 | $4,915,460 | 0.80% |
| First Light Asset Management, LLC | 1,365,343 | $7,454,773 | 0.69% |
| Stonepine Capital Management, LLC | 273,287 | $1,492,147 | 0.63% |
| Mudita Advisors LLP | 90,201 | $492,498 | 0.43% |